Home > Press > Lux Research Releases Event Schedule
Exclusive event features proprietary research, keynote speeches, panels and networking
Lux Research Releases Event Schedule For Lux Executive Summit: The Business Impact of Nanotechnology
New York, NY | June 22, 2005
Lux Research, the world’s leading research and advisory firm for nanotechnology, today released the event schedule for its inaugural Lux Executive Summit: The Business Impact of Nanotechnology, to be held at the Charles Hotel in Cambridge, Massachusetts on October 24–25, 2005.
The Lux Executive Summit is the only event that provides executives and investment managers with the knowledge and insight enabling them to create a winning nanotechnology strategy. The conference is nanotech’s most elite gathering for CEOs, senior corporate executives, fund managers and VCs, scientific pioneers, and public policy makers. Complete event information is available online here.
“The Lux Executive Summit is the premier forum helping executives and investors make better decisions and be better connected than their competitors in nanotechnology,” said Lux Research CEO Peter Hebert. “Our featured participants and attendees range from senior executives at multi-national corporations to start-up CEOs and portfolio managers at leading multi-billion dollar hedge funds.”
Several of the Lux Executive Summit sessions include:
- Myth vs. Reality: Where Nanotech Creates Value for Corporations and Investors (Matthew M. Nordan – Vice President of Research, Lux Research Inc.)
- The Semiconductor Industry’s Nanotech Future (Paolo Gargini – Director of Technology Strategy, Intel)
- Best Practices of Nanotech Serial Entrepreneurs (Larry Bock – Founder and Executive Chairman, Nanosys; Howard Berke – Chairman and CEO, Konarka; David Soane – Founder of Soane Labs LLC and Nano-Tex; Moderator: Jason Pontin – Editor-in-Chief, Technology Review)
- Nanotech Innovation Outlook: Leading Scientists Identify Game-Changing Technologies (Paul Alivisatos – University of California Berkeley; Chad Mirkin – Director, Institute for Nanotechnology; Phil Kuekes – HP Labs; Moderator: Elizabeth Corcoran – Senior Editor, Forbes)
- Heard on The Street: Public Investors’ Views on Nanotech (Michael Mauboussin – Chief Investment Strategist, Legg Mason Capital Management; Pip Coburn – Global Technology Strategist, UBS; Moderator: Josh Wolfe – Managing Partner, Lux Capital)
- Nanotechnology’s Impact on Healthcare and Life Sciences (Norbert Riedel – Chief Scientific Officer, Baxter)
- What’s It Worth: Determining Value for Nanotech Start-ups (David Lackner – Senior Analyst, Lux Research Inc.)
A full event schedule is available at the new Lux Executive Summit website. For early registration discounts, visit www.luxexecutivesummit.com
About Lux Research:
Lux Research is the world's leading nanotechnology research and advisory firm. We help our clients make better decisions to profit from nanoscale science and technology, tapping into our analysts' unique expertise and unrivaled network. Our clients include top decision makers at large corporations, portfolio managers and analysts at leading financial institutions, CEOs of the most innovative start-ups, and visionary public policy makers.
For Lux Executive Summit registration and additional event details, please visit www.luxexecutivesummit.com
To get connected and for more information, visit www.luxresearchinc.com
Peter Hebert of Lux Research, Inc.
Copyright © Lux Research
If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013